Madelyn E. Butler, M.D., joins COLA Inc. Board of Directors

COLA, a national laboratory accreditor dedicated to promoting health and safety through accreditation and education, announces the American Medical Association’s (AMA) appointment of Madelyn E. Butler, MD, to its Board of Directors. Dr. Butler joins COLA’s board of prominent physicians appointed by the AMA, American Academy of Family Physicians (AAFP) and the American College of…

Mary J. James, M.D., joins COLA Inc. Board of Directors

COLA, a national laboratory accreditor dedicated to promoting health and safety through accreditation and education, announces Mary J. James, MD, has been elected to its Board of Directors. Dr. James joins COLA’s board of prominent professionals appointed by the American Medical Association (AMA), American Academy of Family Physicians (AAFP) and the American College of Physicians…

FDA Updates COVID-19 Test Policy and FAQs

COLA Inc. is engaged with the CDC’s Laboratory Outreach Communication System (LOCS) in the Division of Laboratory Systems (DLS) to transmit their public health messages to our laboratories and affiliates.  On September 27, 2022, the CDC alerted laboratories that the Food and Drug Administration had updated its COVID-19 test policy to encourage most test developers to pursue…

CDC Issues Select Agent Gram for Monkeypox Virus

COLA Inc. is engaged with the CDC’s Laboratory Outreach Communication System (LOCS) in the Division of Laboratory Systems (DLS) to transmit their public health messages to our laboratories and affiliates.  On September 15, 2022, the CDC alerted laboratories that the CDC’s Division of Select Agents and Toxins (DSAT) posted a Select Agent (SA) Gram to clarify the regulatory status…

HHS Declaration of Public Health Emergency for Monkeypox Diagnostics and New FDA Guidance

COLA Inc. is engaged with the CDC’s Laboratory Outreach Communication System (LOCS) in the Division of Laboratory Systems (DLS) to transmit their public health messages to our laboratories and affiliates.  On September 9, 2022, the CDC alerted laboratories that the U.S. Department of Health and Human Services (HHS) has declared that the current circumstances justify the authorization…

California Approves COLA’s Pathology Accreditation Program

COLA Inc., a physician-directed organization whose purpose is to promote health and safety through accreditation and educational programs, is proud to announce that the California Department of Public Health, Laboratory Field Services has recently granted COLA the authority to deem California clinical laboratories to be in compliance with California law for the specialty of Pathology,…

Variant Influenza Virus Infections

COLA Inc. is engaged with the CDC’s Laboratory Outreach Communication System (LOCS) in the Division of Laboratory Systems (DLS) to transmit their public health messages to our laboratories and affiliates.  On September 1, 2022, the CDC alerted laboratories about recent variant influenza viral infections. There are five cases of human infection with variant influenza A usually spread…